FAS and central nervous system cancer: Accordingly, inhibition of ERK activation was associated with a reduction of Bcl-XL levels and with an increased sensitivity of siTRPV2 glioma cells to Fas-induced mitochondrial-dependent apoptosis, with the maximal effects observed by using anti-Fas mAb in combination with VP-16 or BCNU [26].